Fused ring azadecalin glucocorticoid receptor modulators

Details for Australian Patent Application No. 2005222421 (hide)

Owner Corcept Therapeutics, Inc.

Inventors Blaney, Paul M.; Hurley, Christopher A.; Williams, Karen; Ray, Nicholas C.; Clark, Robin D.

Agent FB Rice

Pub. Number AU-B-2005222421

PCT Pub. Number WO2005/087769

Priority 60/551,836 09.03.04 US

Filing date 9 March 2005

Wipo publication date 22 September 2005

Acceptance publication date 23 September 2010

International Classifications

C07D 498/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

5 October 2006 PCT application entered the National Phase

  PCT publication WO2005/087769 Priority application(s): WO2005/087769

23 September 2010 Application Accepted

  Published as AU-B-2005222421

20 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005222426-Methods and systems for producing ethanol using raw starch and fractionation

2005222413-High surface area ceramic coated fibers